TABLE 1.
Clinical characteristics of HCC cohorts.
| Clinical features | Training set (n = 240) | Validation set (n = 100) | ICGC-LIRI-JP (n = 243) | |
|---|---|---|---|---|
| Age | <50 | 45 | 21 | 15 |
| ≥50 | 195 | 79 | 228 | |
| Gender | Female | 80 | 28 | 61 |
| Male | 160 | 72 | 182 | |
| T | Early (T1+T2) | 176 | 76 | - |
| Late(T3+T4) | 63 | 23 | - | |
| Unknown | 1 | 1 | - | |
| N | N0 | 172 | 67 | - |
| N1+N2 | 2 | 1 | - | |
| Unknown | 66 | 32 | - | |
| M | M0 | 171 | 73 | - |
| M1 | 1 | 2 | - | |
| Unknown | 68 | 25 | - | |
| Stage | Stage I/II | 166 | 71 | 146 |
| Stage III/IV | 60 | 23 | 97 | |
| Unknown | 14 | 6 | 0 | |
| Grade | G1 | 38 | 14 | - |
| G2 | 114 | 47 | - | |
| G3 | 76 | 35 | - | |
| G4 | 9 | 3 | - | |
| Unknown | 3 | 1 | - | |
| Recurrence | yes | 134 | 44 | - |
| no | 106 | 56 | - | |
| RiskGroup | low risk | 135 | 49 | 199 |
| mid risk | 78 | 40 | 37 | |
| high risk | 27 | 11 | 7 | |
| Status | Alive | 148 | 69 | 199 |
| Dead | 92 | 31 | 44 |